Nkarta is a publicly traded (Nasdaq symbol NKTX), South San Francisco headquartered, clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for cancer patients. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep anti-tumor activity and intended for broad access in the outpatient treatment setting.
Founded in 2015 at the birthplace of biotechnology, our development pipeline of engineered NK cell therapy candidates includes two co-lead clinical programs, NKX101 and NKX019. Clinical trials for NKX101 NKX019 are in process. Nkarta recently announced a collaboration with CRISPR Therapeutics, a world leader in gene-based medicines, for the development and commercialization of up to three new cell therapy candidates and access to clinically validated CRISPR/Cas9 genome engineering.
Complementing our broad research and development capabilities, Nkarta has also built an extensive cell therapy manufacturing operation. We have a 2,700-square foot clinical manufacturing facility on-site at our primary corporate location in South San Francisco, California. In-house manufacturing of NKX019 commenced in 2021, and NKX101 in-house manufacturing is planned to begin in 2022. We are also currently designing a separate, larger cGMP facility, to supply our anticipated pivotal clinical trial and commercial needs.
Nkarta is seeking a highly motivated, collaborative, detail-oriented Sr. Scientist/Scientist to join our Research team. The successful candidate will take part in discovery and IND-enabling activities to bring CAR-therapies to the clinic. They will have a background in immunology, cellular and cancer biology and have the creativity to present new ideas and solve challenging problems. This individual will work independently and with team members to advance the company’s growing pipeline. This role is ideal for an individual who is driven and passionate about cell therapy in a fast-paced collaborative environment.
A reasonable estimate of the current salary range for this position is $115,000 - $165,000. There are several factors taken into consideration in determining base salary, including but not limited to: job-related qualifications, skills, education, and experience, as well as job location and the value of other elements of an employee’s total compensation package. Nkarta also offers an annual discretionary bonus, equity grant(s), medical, dental, vision and life insurance coverage, in accordance with the terms and conditions of the applicable plans. Other benefits include 401K plan, flexible spending account, ESPP, employee assistance program, paid vacation, holiday and personal days, paid parental, pregnancy, and bereavement leave.
The 160+ team members describe working at Nkarta through some of the following comments. While getting better work-life balance and improving communications between groups in an early stage start up environment are two areas in which we’re working, here are real anonymous comments of why people think Nkarta is a great place to work.
To learn more about our work at Nkarta and the career opportunities that will drive us forward to serve patients, please visit the company’s website at https://www.nkartatx.com